Abstract:Idiopathic pulmonary fibrosis (IPF) is an irreversible and fatal lung disease that is primarily found in the elderly population, and several studies have demonstrated that aging is the major risk factor for IPF. IPF is characterized by the presence of apoptosis-resistant, senescent fibroblasts that generate an excessively stiff extracellular matrix (ECM). The ECM profoundly affects cellular functions and tissue homeostasis, and an aberrant ECM is closely associated with the development of lung fibrosis. Aging progressively alters ECM components and is associated with the accumulation of senescent cells that promote age-related tissue dysfunction through the expression of factors linked to a senescence-associated secretary phenotype (SASP). There is growing evidence that SASP factors affect various cell behaviors and influence ECM turnover in lung tissue through autocrine and/or paracrine signaling mechanisms. Since life expectancy is increasing worldwide, it is important to elucidate how aging affects ECM dynamics and turnover via SASP and thereby promotes lung fibrosis. In this review, we will focus on the molecular properties of SASP and its regulatory mechanisms. Furthermore, the pathophysiological process of ECM remodeling by SASP factors and the influence of an altered ECM from aged lungs on the development of lung fibrosis will be highlighted. Finally, recent attempts to target ECM alteration and senescent cells to modulate fibrosis will be introduced.NEW & NOTEWORTHY Aging is the most prominent nonmodifiable risk factor for various human diseases including Idiopathic pulmonary fibrosis. Aging progressively alters extracellular matrix components and is associated with the accumulation of senescent cells that promote age-related tissue dysfunction. In this review, we will discuss the pathological impact of aging and senescence on lung fibrosis via senescence-associated secretary phenotype factors and potential therapeutic approaches to limit the progression of lung fibrosis.

Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis Via Differential Cellular Pathways

Fat Infiltration in Skeletal Muscle: Influential Triggers and Regulatory Mechanism.

Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy

Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis

Decoding the role of fatty acids and their metabolites in lung fibrosis

High-Fat Diet Related Lung Fibrosis-Epigenetic Regulation Matters

Immune cells crosstalk Pathways, and metabolic alterations in Idiopathic pulmonary fibrosis

Pulmonary fibrosis: pathogenesis and therapeutic strategies

A Troy Horse in Pulmonary Fibrosis

Effect of lipid saturation and oxidation on fibrogenesis in IPF

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?

[Lipid metabolism in idiopathic pulmonary fibrosis]

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)

Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential

Impact of different ectopic fat depots on cardiovascular and metabolic diseases

The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype

Obesity and the Development of Lung Fibrosis

Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis